European equities traded in the US as American depositary receipts fell late Friday morning with the S&P Europe Select ADR Index declining 0.5% to 1,533.9.

From continental Europe, the decliners were led by biotech firm BioNTech (BNTX) and biopharmaceutical company DBV Technologies (DBVT), which fell 3.7% and 2.2% respectively. They were followed by telecommunications company Nokia (NOK) and Royal Philips (PHG), which were down 2.1% and 1.5% respectively.

The gainers from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and furniture maker Natuzzi (NTZ), which rose 3.9% and 3.6% respectively. They were followed by biopharmaceutical company Genfit (GNFT) and pharmaceutical company Novo Nordisk (NVO), which were up 1.4% and 1% respectively.

From the UK and Ireland, the decliners were led by biopharmaceutical company Akari Therapeutics (AKTX) and software firm Endava (DAVA), which dropped 2.4% and 1.8% respectively. They were followed by medical device maker Smith & Nephew (SNN) and cruise line operator Carnival (CUK), which lost 1.3% and 1.2% respectively.

The gainers from the UK and Ireland were led by biopharmaceutical companies NuCana (NCNA) and Adaptimmune Therapeutics (ADAP), which advanced 11% and 6.1% respectively. They were followed by biotech company Autolus Therapeutics (AUTL) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which increased 1.4% and 1.2% respectively.